sanofi ceo: we’re buying cancer-biotech firm synthorx for $2.5 billion
Published 4 years ago • 4.2K plays • Length 5:45Download video MP4
Download video MP3
Similar videos
-
7:37
sanofi ceo paul hudson on r&d day: we're going to be the world's leading immunology company
-
5:00
sanofi ceo paul hudson: we've got perhaps the world's best immunology pipeline
-
4:03
sanofi ceo: real breakthrough in rsv treatment is 'right around the corner'
-
8:31
regeneron to buy sanofi's cancer drug in $1b deal
-
1:36
sanofi ceo on coronavirus vaccine development and the pressure 'to get it right'
-
4:13
sanofi ceo paul hudson on cancer research, covid-19 vaccine and more
-
1:03
france's sanofi to buy synthorx for $2.5 billion
-
32:36
sanofi’s ceo on how company culture can thrive in a distributed, hybrid world
-
8:42
astrazeneca ceo pascal soriot goes one-on-one with jim cramer
-
7:45
innovent biologics ceo on pharma industry, prices, pipeline, cancer cure
-
2:54
sanofi ceo: dupixent eczema drug is game-changing for the company
-
2:04
sanofi, glaxosmithkline reach $2.1 billion deal with u.s. to supply vaccine doses
-
2:08
pfizer offers $43 billion to buy cancer drugmaker seagen
-
3:17
sanofi ousts chief executive
-
0:54
pfizer ceo: cancer drugs will be our next big contribution to the world
-
1:12
sanofi – our leaders at vivatech 2024
-
0:28
novartis acquiring cancer drug developer morphosys for €2.7 billion
-
17:57
how biontech used cancer research to create its covid vaccine
-
5:21
combating cancer: cynvenio ceo & cso | mad money | cnbc
-
7:48
sanofi ceo on breakthroughs in cancer research, covid-19 vaccine development, and drug pricing
-
6:04
karyopharm therapeutics ceo: combatting cancer | mad money | cnbc